Vaughan, Thomas L.
Fitzgerald, Rebecca C.
Article History
First Online: 10 February 2015
Competing interests
: R.C.F. developed the Cytosponge technology with MRC-Technology and is named on related patents. The technology has recently been licensed to Covidien GI Solutions; R.C.F. has no direct financial relationship with Covidien. T.L.V. declares no competing interests.